Investigation of B,C-ring truncated deguelin derivatives as heat shock protein 90 (HSP90) inhibitors for use as anti-breast cancer agents-Reference-Cited by-同舟云学术

Investigation of B,C-ring truncated deguelin derivatives as heat shock protein 90 (HSP90) inhibitors for use as anti-breast cancer agents

Published:2019-04 Issue:7 Volume:27 Page:1370-1381
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Kim Ho Shin,Hoang Van-Hai,Hong Mannkyu,Chul Kim Kyung,Ann Jihyae,Nguyen Cong-Truong,Seo Ji Hae,Choi Hoon,Yong Kim Jun,Kim Kyu-Won,Sub Byun Woong,Lee Sangkook,Lee Seungbeom,Suh Young-Ger,Chen Jie,Park Hyun-Ju,Cho Tae-Min,Kim Ji Young,Seo Jae Hong,Lee Jeewoo

Funder

Korea Health Industry Development Institute

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference34 articles.

1. mTOR signaling in growth control and disease;Trepel;Cell,2012

2. HSP90 and the chaperoning of cancer;Whitesell;Nat Rev Cancer,2005

3. Hallmarks of cancer;Hanahan;Cell,2000

4. Inhibition of Hsp90 down-regulates mutant epidermal growth factor receptor (EGFR) expression and sensitizes EGFR mutant tumors to paclitaxel;Sawai;Cancer Res,2008

5. Targeting heat shock protein 90 with CUDC-305 overcomes erlotinib resistance in non-small cell lung cancer;Bao;Mol Cancer Ther,2009

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of indazole inhibitors for heat shock protein 90 as anti-cancer agents;European Journal of Medicinal Chemistry;2024-10

2. Heat shock proteins as hallmarks of cancer: insights from molecular mechanisms to therapeutic strategies;Journal of Hematology & Oncology;2024-09-04

3. Small molecule inhibitors targeting heat shock protein 90: An updated review;European Journal of Medicinal Chemistry;2024-09

4. Synthesis of C3′‐Foused Aryl/Penta‐1,4‐Dien‐3‐One/Amine Hybrids as HSP90C‐Terminal Inhibitors;Chemistry & Biodiversity;2024-07-24

5. Discovery of novel diaryl substituted isoquinolin-1(2H)-one derivatives as hypoxia-inducible factor-1 signaling inhibitors for the treatment of rheumatoid arthritis;European Journal of Medicinal Chemistry;2024-05